Most cited papers from Chiesi (Italy)

Chiesi (Italy)

What are the most cited papers from Chiesi (Italy)?

The most cited paper from Chiesi (Italy) is "A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease" (Francesco Panza, Madia Lozupone, Giancarlo Logroscino et al., 2019), with 984 citations. Next come "4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1" (774) and "The β-Secretase BACE1 in Alzheimer’s Disease" (695).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 111 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease Francesco Panza, Madia Lozupone, Giancarlo Logroscino et al. · Nature Reviews Neurology Review	4 Jan 2019	984
2	4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1 Marcello Trevisani, Jan Siemens, Serena Materazzi et al. · Proceedings of the National Academy of Sciences Open access	7 Aug 2007	774
3	The β-Secretase BACE1 in Alzheimer’s Disease Harald Juergen Hampel et al. · Biological Psychiatry Open access	12 Feb 2020	695
4	Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial Alberto A. Papi, Jørgen Vestbo, Leonardo Michele Fabbri et al. · The Lancet Open access	9 Feb 2018	636
5	Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort Dominick E. Shaw et al. · European Respiratory Journal Open access	10 Sep 2015	564
6	Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial Jørgen Vestbo, Alberto A. Papi, Massimo Corradi et al. · The Lancet Open access	3 Apr 2017	445
7	Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial Dave Singh, Alberto A. Papi, Massimo Corradi et al. · The Lancet Open access	Sep 2016	432
8	Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study Dirkje Sjoukje Postma et al. · The Lancet Respiratory Medicine Open access	12 Mar 2019	402
9	Cigarette smoke–induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodents Eunice Andrè, Barbara Campi, Serena Materazzi et al. · Journal of Clinical Investigation Open access	Jun 2008	375
10	A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease Harald Juergen Hampel et al. · Frontiers in Immunology Open access	31 Mar 2020	356
11	Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review Vincenzo Solfrizzi, Carlo Custodero, Madia Lozupone et al. · Journal of Alzheimer s Disease Review	5 Jul 2017	354
12	Prophylactic or Early Selective Surfactant Combined With nCPAP in Very Preterm Infants Fabrizio Sandri, Richard Plavka, Gina Ancora et al. · PEDIATRICS	4 May 2010	354
13	The role of small intestinal bacterial overgrowth in Parkinson's disease Alfonso A. Fasano, Francesco Bove, Maurizio Gabrielli et al. · Movement Disorders	27 May 2013	348
14	The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population Roberto de Marco, Giancarlo Pesce, Alessandro Marcon et al. · PLoS ONE Open access	10 May 2013	345
15	Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B Wolfgang Miesbach, Karina Meijer, Michiel Coppens et al. · Blood Open access	15 Dec 2017	304
16	Diet and Alzheimer’s disease risk factors or prevention: the current evidence Vincenzo Solfrizzi, Francesco Panza, Vincenza Frisardi et al. · Expert Review of Neurotherapeutics	May 2011	304
17	Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective Christopher P. Austin et al. · Clinical and Translational Science Open access	10 Aug 2017	255
18	Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment? Bruno Pietro Imbimbo · Frontiers in Aging Neuroscience Open access	2010	241
19	Transient Receptor Potential Ankyrin 1 Channel Localized to Non-Neuronal Airway Cells Promotes Non-Neurogenic Inflammation Romina Nassini, Pamela Pedretti, Nadia Moretto et al. · PLoS ONE Open access	14 Aug 2012	238
20	Multivariate Prediction of Subcutaneous Glucose Concentration in Type 1 Diabetes Patients Based on Support Vector Regression Eleni I. Georga, Vasilios C. Protopappas, Diego Ardigò et al. · IEEE Journal of Biomedical and Health Informatics	19 Sep 2012	226
21	Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging Vincenzo Solfrizzi, Emanuele Scafato, Vincenza Frisardi et al. · Alzheimer s & Dementia	12 Dec 2012	223
22	Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials Johann Christian Virchow Jr., Piotr Kuna, Pierluigi Paggiaro et al. · The Lancet Open access	30 Sep 2019	216
23	γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes Bruno Pietro Imbimbo, Giuseppe A. M. Giardina · Current Topics in Medicinal Chemistry	30 May 2011	201
24	Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease Francesco Panza, Vincenzo Solfrizzi, Davide Seripa et al. · BioMed Research International Open access	2016	192
25	Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging Vincenzo Solfrizzi et al. · Journal of the American Medical Directors Association	22 Dec 2016	190
26	Nutraceutical Properties of Mediterranean Diet and Cognitive Decline: Possible Underlying Mechanisms Vincenza Frisardi, Francesco Panza, Davide Seripa et al. · Journal of Alzheimer s Disease	25 Nov 2010	183
27	α,β-Unsaturated Aldehydes in Cigarette Smoke Release Inflammatory Mediators from Human Macrophages Fabrizio Facchinetti, Francesco Amadei, Pierangelo Geppetti et al. · American Journal of Respiratory Cell and Molecular Biology	28 Jun 2007	182
28	Amyloid‐β immunotherapy for alzheimer disease: Is it now a long shot? Francesco Panza, Madia Lozupone, Davide Seripa et al. · Annals of Neurology	12 Jan 2019	179
29	The prevalence of small airways disease in adult asthma: A systematic literature review Omar S. Usmani, Dave Singh, Monica Spinola et al. · Respiratory Medicine ReviewOpen access	8 May 2016	174
30	Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1 Serena Materazzi, Romina Nassini, Eunice Andrè et al. · Proceedings of the National Academy of Sciences Open access	7 Aug 2008	174
31	Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms Francesco Panza, Vincenza Frisardi, Cristiano A. Capurso et al. · Journal of Alzheimer s Disease	2 Sep 2010	162
32	Time to test antibacterial therapy in Alzheimer’s disease Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi et al. · Brain Open access	25 Jul 2019	161
33	Hydrogen sulfide causes vanilloid receptor 1‐mediated neurogenic inflammation in the airways Marcello Trevisani, Riccardo Patacchini, Paola Nicoletti et al. · British Journal of Pharmacology Open access	6 Jun 2005	159
34	Asthma progression and mortality: the role of inhaled corticosteroids Paul M. O’Byrne, Leonardo Michele Fabbri, Ian Douglas Pavord et al. · European Respiratory Journal Open access	2 May 2019	158
35	Methods for Assessing Percutaneous Absorption Doug Howes, Richard H. Guy, Jonathan Hadgraft et al. · Alternatives to Laboratory Animals	1996	155
36	Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study on behalf of the LIAISON Study Group, Fulvio Braido, Guy Brusselle et al. · Respiratory Research Open access	13 May 2016	155
37	Drug/Cyclodextrin/Hydroxy Acid Multicomponent Systems. Properties and Pharmaceutical Applications Enrico Redenti, Lajos Szente, József Szejtli · Journal of Pharmaceutical Sciences	2000	146
38	Beclomethasone/formoterolversusbudesonide/formoterol combination therapy in asthma Alberto A. Papi, Pierluigi Paggiaro, Gabriele Nicolini et al. · European Respiratory Journal Open access	15 Nov 2006	145
39	Therapeutic Potential of γ -Secretase Inhibitors and Modulators Bruno Pietro Imbimbo · Current Topics in Medicinal Chemistry	2008	144
40	The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study Monica Kraft et al. · The Lancet Respiratory Medicine Open access	2 Mar 2022	143
41	Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development Robin Heise Steinhorn, Jonathan M. Davis, Wolfgang Göpel et al. · The Journal of Pediatrics Open access	22 Nov 2017	143
42	Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma Alberto A. Papi, Pier Luigi Paggiaro, Gabriele Nicolini et al. · Allergy Open access	5 Sep 2007	141
43	Lung function and asthma control with beclomethasone and formoterol in a single inhaler Gérard Huchon, HELGO MAGNUSSEN, А. Г. Чучалин et al. · Respiratory Medicine Open access	4 Nov 2008	139
44	Efficient protein production inspired by how spiders make silk Nina Kronqvist, Médoune Sarr, Anton Lindqvist et al. · Nature Communications Open access	23 May 2017	138
45	Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice Francesco De Logu, Simone Li Puma, Lorenzo Landini et al. · Journal of Clinical Investigation Open access	5 Sep 2019	133
46	Investigational BACE inhibitors for the treatment of Alzheimer’s disease Bruno Pietro Imbimbo, Mark I L Watling · Expert Opinion on Investigational Drugs	29 Oct 2019	131
47	Characterization of a surface modified dry powder inhalation carrier prepared by “particle smoothing” Paul Michael Young, Daniela Cocconi, Paolo Angelo Colombo et al. · Journal of Pharmacy and Pharmacology	Oct 2002	130
48	Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Francesco Panza, Vincenza Frisardi, Davide Seripa et al. · International Journal of Geriatric Psychiatry	7 Mar 2012	130
49	Neutrophil elastase in bronchiectasis Andrea Gramegna, Francesco Amati, Leonardo Terranova et al. · Respiratory Research Open access	Dec 2017	129
50	Development of disease-modifying drugs for frontotemporal dementia spectrum disorders Francesco Panza, Madia Lozupone, Davide Seripa et al. · Nature Reviews Neurology Review	23 Mar 2020	128

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.